Alcohol cessation and breast cancer risk stratified by hormone receptor status

被引:0
|
作者
Terry, Mary Beth [1 ,2 ]
English, Dallas R. [3 ,4 ]
Freudenheim, Jo L. [5 ]
Lauby-Secretan, Beatrice [6 ]
Gapstur, Susan M. [7 ]
机构
[1] Columbia Univ, Irving Med Ctr, Mailman Sch Publ Hlth, New York, NY 10027 USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY 10027 USA
[3] Univ Melbourne, Canc Council Victoria, Melbourne, Vic, Australia
[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
[5] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Buffalo, NY USA
[6] Int Agcy Res Canc, Lyon, France
[7] Epidemiol Consultant, Tiffin, IA USA
关键词
Breast cancer; Alcoholic beverages; Alcohol cessation; Risk reduction; Hormone receptor; Estrogen receptor; CONSUMPTION; WOMEN;
D O I
10.1186/s13058-024-01937-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because alcohol consumption is an established cause of female breast cancer, understanding whether cessation affects risk is of public health importance. In a recent meta-analysis, compared with continuing consumption, the relative risk (RR) for cessation was 0.95 (95% confidence interval [CI] 0.88-1.01). Because intake of alcohol is more consistently associated with estrogen receptor positive (ER+) than negative (ER-) subtypes, we conducted a meta-analysis of alcohol cessation for ER-specific breast cancer risk using data from three cohort studies and one population-based case-control study (ER + n = 3,793; ER- n = 627) with information reported on cessation and ER status. Compared with continuing consumption, cessation was associated with lower risk of ER+ (RR = 0.88, 95%CI, 0.79-0.98) but not ER- (RR = 1.23, 95%CI, 0.98-1.55) breast cancer. These results suggest that, compared with continuing consumption, alcohol cessation may reduce ER + but not ER- breast cancer risk. However, research that considers duration of cessation is warranted.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Alcohol and Risk of Breast Cancer by Histologic Type and Hormone Receptor Status in Postmenopausal Women
    Lew, Jasmine Q.
    Freedman, Neal D.
    Leitzmann, Michael F.
    Brinton, Louise A.
    Hoover, Robert N.
    Hollenbeck, Albert R.
    Schatzkin, Arthur
    Park, Yikyung
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (03) : 308 - 317
  • [2] Breast cancer risk associated with alcohol consumption depends on hormone receptor status.
    Enger, SM
    Ross, RK
    Paganini-Hill, A
    Longnecker, MP
    Bernstein, L
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S35 - S35
  • [3] SSRI use and breast cancer risk by hormone receptor status
    Coogan, Patricia F.
    Strom, Brian L.
    Rosenberg, Lynn
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 527 - 531
  • [4] SSRI use and breast cancer risk by hormone receptor status
    Patricia F. Coogan
    Brian L. Strom
    Lynn Rosenberg
    Breast Cancer Research and Treatment, 2008, 109 : 527 - 531
  • [5] Fruit and Vegetable Intake and Risk of Breast Cancer by Hormone Receptor Status
    Jung, Seungyoun
    Spiegelman, Donna
    Baglietto, Laura
    Bernstein, Leslie
    Boggs, Deborah A.
    van den Brandt, Piet A.
    Buring, Julie E.
    Cerhan, James R.
    Gaudet, Mia M.
    Giles, Graham G.
    Goodman, Gary
    Hakansson, Niclas
    Hankinson, Susan E.
    Helzlsouer, Kathy
    Horn-Ross, Pamela L.
    Inoue, Manami
    Krogh, Vittorio
    Lof, Marie
    McCullough, Marjorie L.
    Miller, Anthony B.
    Neuhouser, Marian L.
    Palmer, Julie R.
    Park, Yikyung
    Robien, Kim
    Rohan, Thomas E.
    Scarmo, Stephanie
    Schairer, Catherine
    Schouten, Leo J.
    Shikany, James M.
    Sieri, Sabina
    Tsugane, Schoichiro
    Visvanathan, Kala
    Weiderpass, Elisabete
    Willett, Walter C.
    Wolk, Alicja
    Zeleniuch-Jacquotte, Anne
    Zhang, Shumin M.
    Zhang, Xuehong
    Ziegler, Regina G.
    Smith-Warner, Stephanie A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (03): : 219 - 236
  • [6] Predicting risk of breast cancer in postmenopausal women by hormone receptor status
    Chlebowski, Rowan T.
    Anderson, Garnet L.
    Lane, Dorothy S.
    Aragaki, Aaron K.
    Rohan, Thomas
    Yasmeen, Shagufta
    Sarto, Gloria
    Rosenberg, Carol A.
    Hubbell, F. Allan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (22): : 1695 - 1705
  • [7] Association of aspirin use and hormone receptor status with breast cancer risk
    Woloshin, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (12): : 1426 - 1427
  • [8] Folate intake and risk of breast cancer characterized by hormone receptor status
    Zhang, SM
    Hankinson, SE
    Hunter, DJ
    Giovannucci, EL
    Colditz, GA
    Willett, WC
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (08) : 2004 - 2008
  • [9] Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status
    Jiang, He-Sheng
    Kuang, Xia-Ying
    Sun, Wei-Li
    Xu, Yan
    Zheng, Yi-zi
    Liu, Yi-Rong
    Lang, Guan-Tian
    Qiao, Feng
    Hu, Xin
    Shao, Zhi-Ming
    ONCOTARGET, 2016, 7 (27): : 41285 - 41293
  • [10] Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status
    Huesing, Anika
    Canzian, Federico
    Beckmann, Lars
    Garcia-Closas, Montserrat
    Diver, W. Ryan
    Thun, Michael J.
    Berg, Christine D.
    Hoover, Robert N.
    Ziegler, Regina G.
    Figueroa, Jonine D.
    Isaacs, Claudine
    Olsen, Anja
    Viallon, Vivian
    Boeing, Heiner
    Masala, Giovanna
    Trichopoulos, Dimitrios
    Peeters, Petra H. M.
    Lund, Eiliv
    Ardanaz, Eva
    Khaw, Kay-Tee
    Lenner, Per
    Kolonel, Laurence N.
    Stram, Daniel O.
    Le Marchand, Loic
    McCarty, Catherine A.
    Buring, Julie E.
    Lee, I-Min
    Zhang, Shumin
    Lindstroem, Sara
    Hankinson, Susan E.
    Riboli, Elio
    Hunter, David J.
    Henderson, Brian E.
    Chanock, Stephen J.
    Haiman, Christopher A.
    Kraft, Peter
    Kaaks, Rudolf
    JOURNAL OF MEDICAL GENETICS, 2012, 49 (09) : 601 - 608